FI863077A7 - Farmaseuttinen annosyksikkö. - Google Patents

Farmaseuttinen annosyksikkö. Download PDF

Info

Publication number: FI863077A7
Authority: FI; Finland
Prior art keywords: dosage unit; pharmaceutical dosage; pharmaceutical; unit; dosage
Prior art date: 1985-07-29

Application number

FI863077A

Other languages

English (en)

Swedish (sv)

Other versions

FI863077L (fi

FI863077A0 (fi

Inventor

Thomas Robert Malefyt

Chester Allen Meyers

Original Assignee

Smithkline Beckman Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-29

Filing date

1986-07-28

Publication date

1987-01-30

1986-07-28 Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp

1986-07-28 Publication of FI863077A0 publication Critical patent/FI863077A0/fi

1987-01-30 Publication of FI863077L publication Critical patent/FI863077L/fi

1987-01-30 Publication of FI863077A7 publication Critical patent/FI863077A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI863077A 1985-07-29 1986-07-28 Farmaseuttinen annosyksikkö. FI863077A7 (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US75978585A	1985-07-29	1985-07-29

Publications (3)

Publication Number	Publication Date
FI863077A0 FI863077A0 (fi)	1986-07-28
FI863077L FI863077L (fi)	1987-01-30
FI863077A7 true FI863077A7 (fi)	1987-01-30

Family

ID=25056946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI863077A FI863077A7 (fi)	1985-07-29	1986-07-28	Farmaseuttinen annosyksikkö.

Country Status (15)

Country	Link
EP (1)	EP0211592A3 (fi)
JP (1)	JPS6236332A (fi)
KR (1)	KR870000918A (fi)
CN (1)	CN86105526A (fi)
AU (1)	AU593566B2 (fi)
DK (1)	DK352686A (fi)
ES (1)	ES2000743A6 (fi)
FI (1)	FI863077A7 (fi)
GR (1)	GR861961B (fi)
HU (1)	HU198264B (fi)
NO (1)	NO863029L (fi)
PH (1)	PH22989A (fi)
PT (1)	PT83075B (fi)
ZA (1)	ZA865652B (fi)
ZW (1)	ZW14486A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL78937A (en) *	1985-05-28	1990-11-29	Wellcome Found	Pharmaceutical compositions containing tissue-plasminogen activator
US4929444A (en) *	1985-05-28	1990-05-29	Burroughs Wellcome Co.	Low pH pharmaceutical formulation containing t-PA
US4777043A (en) *	1985-12-17	1988-10-11	Genentech, Inc.	Stabilized human tissue plasminogen activator compositions
US5034225A (en) *	1985-12-17	1991-07-23	Genentech Inc.	Stabilized human tissue plasminogen activator compositions
DE3845000C2 (de) *	1987-07-10	1998-11-19	Novartis Ag	Anwendung von Octreotid zur Behandlung von Brustkrebs
US4929560A (en) *	1988-02-03	1990-05-29	Damon Biotech, Inc.	Recovery of tissue plasminogen activator
DE3806562A1 (de) *	1988-03-01	1989-09-14	Alpha Therapeutic Gmbh	Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff
US5270198A (en) *	1988-05-20	1993-12-14	Genentech, Inc.	DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) *	1988-06-20	1988-07-27	Wellcome Found	Medicaments
US5342616A (en) *	1988-06-20	1994-08-30	The Wellcome Foundation Limited	Method of administering tissue plasminogen activator
US5262170A (en) *	1988-09-02	1993-11-16	Genentech, Inc.	Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) *	1988-09-02	1998-02-03	Genentech, Inc.	Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3835350A1 (de) *	1988-10-17	1990-04-19	Boehringer Mannheim Gmbh	Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US4980165A (en) *	1989-01-27	1990-12-25	Genetics Institute, Inc.	Pharmaceutical formulations of plasminogen activator proteins
CA2027936C (en)	1989-10-23	2001-07-24	Smithkline Beecham Corporation	Cyclic anti-aggregatory peptides
DE3942143A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	T-pa pro stabilisierung
US5366730A (en) *	1989-12-20	1994-11-22	Boehringer Mannheim Gmbh	Stabilized compositions having human tissue type plasminogen activator enzymatic activity
DE3942142A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	Stabilisierung von glykosyliertem t-pa
DE3942144A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	Stabilisierung von k1k2p pro
DE3942145A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	T-pa-solubilisierung
DE3942141A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	K2p pro-stabilisierung
DK0580685T3 (da) *	1991-04-16	1996-03-04	Boehringer Mannheim Gmbh	Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift
US5272076A (en) *	1991-06-13	1993-12-21	Eli Lilly And Company	Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US5747447A (en) *	1992-04-30	1998-05-05	Cor Therapeutics	Stable polypeptide composition
WO1993024635A1 (en) *	1992-06-03	1993-12-09	Genentech, Inc.	Tissue plasminogen activator glycosylation variants with improved therapeutic properties
AU2005274822B2 (en)	2004-07-26	2008-10-30	Merz Pharma Gmbh & Co. Kgaa	Therapeutic composition with a botulinum neurotoxin
KR102194891B1 (ko)	2020-07-08	2020-12-28	대상 주식회사	계란프라이 조리장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8003402A (nl) *	1980-06-11	1982-01-04	Leuven Res & Dev Vzw	Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
JPS59196824A (ja) *	1983-04-21	1984-11-08	Kowa Co	吸着防止剤
IL78937A (en) *	1985-05-28	1990-11-29	Wellcome Found	Pharmaceutical compositions containing tissue-plasminogen activator
US4929444A (en) *	1985-05-28	1990-05-29	Burroughs Wellcome Co.	Low pH pharmaceutical formulation containing t-PA
JPH0672105B2 (ja) *	1985-10-02	1994-09-14	持田製薬株式会社	血栓溶解剤及びその製法

1986
- 1986-07-23 ZW ZW144/86A patent/ZW14486A1/xx unknown
- 1986-07-24 ES ES8600558A patent/ES2000743A6/es not_active Expired
- 1986-07-24 DK DK352686A patent/DK352686A/da not_active Application Discontinuation
- 1986-07-25 GR GR861961A patent/GR861961B/el unknown
- 1986-07-28 EP EP86305794A patent/EP0211592A3/en not_active Withdrawn
- 1986-07-28 HU HU863218A patent/HU198264B/hu not_active IP Right Cessation
- 1986-07-28 FI FI863077A patent/FI863077A7/fi not_active Application Discontinuation
- 1986-07-28 KR KR1019860006133A patent/KR870000918A/ko not_active Withdrawn
- 1986-07-28 CN CN198686105526A patent/CN86105526A/zh active Pending
- 1986-07-28 NO NO863029A patent/NO863029L/no unknown
- 1986-07-28 PT PT83075A patent/PT83075B/pt unknown
- 1986-07-28 PH PH34074A patent/PH22989A/en unknown
- 1986-07-29 JP JP61179812A patent/JPS6236332A/ja active Pending
- 1986-07-29 AU AU60647/86A patent/AU593566B2/en not_active Ceased
- 1986-07-29 ZA ZA865652A patent/ZA865652B/xx unknown

Also Published As

Publication number	Publication date
DK352686A (da)	1987-01-30
NO863029L (no)	1987-01-30
AU6064786A (en)	1987-02-05
EP0211592A3 (en)	1988-03-02
PH22989A (en)	1989-02-24
FI863077L (fi)	1987-01-30
ES2000743A6 (es)	1988-03-16
FI863077A0 (fi)	1986-07-28
DK352686D0 (da)	1986-07-24
JPS6236332A (ja)	1987-02-17
HUT42953A (en)	1987-09-28
NO863029D0 (no)	1986-07-28
AU593566B2 (en)	1990-02-15
CN86105526A (zh)	1987-02-04
HU198264B (en)	1989-09-28
GR861961B (en)	1986-11-26
EP0211592A2 (en)	1987-02-25
PT83075B (en)	1988-07-13
ZW14486A1 (en)	1986-10-22
ZA865652B (en)	1987-11-25
PT83075A (en)	1986-08-01
KR870000918A (ko)	1987-03-10

Publication	Publication Date	Title
NO863029D0 (no)	1986-07-28	Farmasoeytisk doseringsenhet.
FI862479L (fi)	1986-12-12	Oral farmaceutisk komposition.
DK546886D0 (da)	1986-11-14	Farmaceutisk praeparat
DK175487A (da)	1987-04-06	Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
FI863094L (fi)	1987-01-31	Anordning foer administrering av laekemedel till patienter.
FI864605L (fi)	1987-05-16	Terapeutiska sammansaettningar.
MX9203170A (es)	1992-07-01	Composicion farmaceutica con actividad analgesica.
NO882653D0 (no)	1988-06-15	Doseringsform.
FI854573A0 (fi)	1985-11-20	Farmaceutiska kapslar med foerdroejd frigoering.
DE3682083D1 (de)	1991-11-28	Pharmazeutische zusammensetzungen.
DE68907177D1 (de)	1993-07-22	Dosierungsform.
DE3683664D1 (de)	1992-03-12	Pharmazeutisches tablettierverfahren.
DE3682960D1 (de)	1992-01-30	Pharmazeutische praeparate.
DE3674040D1 (de)	1990-10-18	Pharmazeutische zusammensetzungen.
IT1213453B (it)	1989-12-20	Composizione farmaceutica.
DE3576118D1 (de)	1990-04-05	Pharmazeutische praeparate.
DK548689A (da)	1990-05-05	Farmaceutisk oploesning
NO863625D0 (no)	1986-09-10	Medikamentdoseringsanordning.
FI865069L (fi)	1987-06-15	Terapeutiskt system.
FI852658A7 (fi)	1986-01-07	Farmaseuttiset aineet.
ES297038Y (es)	1988-12-01	Tableta farmaceutica.
FI875616A0 (fi)	1987-12-21	Farmaceutiska blandningar.
IT8520591A0 (it)	1985-05-06	Formulazione farmaceutica.
DE3667915D1 (de)	1990-02-08	Pharmazeutische zusammensetzung.
BE890817A (fr)	1982-02-15	Medicaments pschycotropes

Legal Events

Date	Code	Title	Description
2004-08-31	FD	Application lapsed	Owner name: SMITHKLINE BECKMAN CORPORATION